Changes in Tissue Microcirculation During Ischemic Conditioning: Pilot Study

February 26, 2018 updated by: Yunseok Jeon, Seoul National University Hospital
Changes in tissue microcirculation during ischemic conditioning (4 cycles of 5-min ischemia and 5-min reperfusion) has not been well documented. In previous studies, there was difference in changes in microcirculation, such as recovery slope and occlusion slope, between healthy subjects and cardiac surgery patients. Moreover, the occlusion slope, which reflects local tissue oxygen consumption during ischemic period, is anticipated to decrease during repeated ischemia-reperfusion cycle by its protecting effect, however there has not been well-conducted study. The purpose of the study is to evaluate the changes in microcirculation measured by tissue oxygen saturation during ischemic conditioning between healthy volunteers and cardiac surgery patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Subjects who are male healthy volunteers (aged 20-45) or who are scheduled to receive cardiac surgery (aged 20-80) will undergo ischemic conditioning, consisting of 4 cycles of 5-min ischemia with pressure of 200 mmHg on upper extremity followed by 5-min reperfusion with no pressure. During ischemic conditioning, changes in tissue microcirculation (baseline tissue saturation, occlusion slope during ischemia, and recovery slope during reperfusion) will be observed using tissue oxygen saturation sensor attached to the thenar muscle of the hand. For cardiac surgery patients, the study will be conducted before anesthesia induction on the surgery day to exclude any potential effect of anesthetics.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

<Healthy volunteers>

Inclusion Criteria:

  • Age 20-45
  • No underlying chronic disease
  • Male volunteer

Exclusion Criteria:

  • Under taking prescription drugs
  • Taking herbal medicines within 2 weeks
  • Baseline systolic blood pressure > 150 mmHg or diastolic pressure > 100 mmHg
  • Body mass index < 18 kg/m^2 or > 30 kg/m^2
  • Vigorous exercise, excessive alcohol, smoking or caffeine within 24 hours
  • Any abnormalities on upper extremities
  • Do not consent to participate

<Cardiac surgery patients>

Inclusion Criteria:

  • Age 20-80
  • Scheduled for cardiac surgery

Exclusion Criteria:

  • Baseline systolic blood pressure > 150 mmHg or diastolic pressure > 100 mmHg
  • Body mass index < 18 kg/m^2 or > 30 kg/m^2
  • Uncontrolled diabetes
  • Under taking beta-blockers
  • Severe renal dysfunction, chronic kidney disease, on hemodialysis
  • Any abnormalities on upper extremities (i.e, AV fistula on arms)
  • Peripheral vascular disease, peripheral neuropathy, coagulopathy
  • Vigorous exercise, excessive alcohol, smoking or caffeine within 24 hours
  • Pregnant
  • Emergency surgery
  • Do not consent to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Healthy volunteers
Healthy male volunteers will receive ischemic conditioning (4 cycles of 5-min ischemia followed by 5-min reperfusion on upper extremity) while measuring changes in tissue microcirculation at the thenar muscle.
Four cycles of 5-min inflation of pneumatic cuff on upper extremity up to 200 mmHg, followed by 5-min deflation with no pressure.
Active Comparator: Cardiac surgery patients
Patients scheduled for cardiac surgery will receive ischemic conditioning (4 cycles of 5-min ischemia followed by 5-min reperfusion on upper extremity) while measuring changes in tissue microcirculation at the thenar muscle.
Four cycles of 5-min inflation of pneumatic cuff on upper extremity up to 200 mmHg, followed by 5-min deflation with no pressure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in microcirculation during ischemic conditioning
Time Frame: During 4-cycles of 5-min ischemia followed by 5-min reperfusion
Changes in occlusion slope during ischemia and recovery slope during reperfusion
During 4-cycles of 5-min ischemia followed by 5-min reperfusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2017

Primary Completion (Actual)

July 10, 2017

Study Completion (Actual)

July 10, 2017

Study Registration Dates

First Submitted

March 14, 2017

First Submitted That Met QC Criteria

March 20, 2017

First Posted (Actual)

March 24, 2017

Study Record Updates

Last Update Posted (Actual)

February 28, 2018

Last Update Submitted That Met QC Criteria

February 26, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RIPC-VOT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Microcirculation

Clinical Trials on ischemic conditioning

3
Subscribe